Given after surgery, AZ’s Tagrisso prevents lung cancer comi...

AstraZeneca opened its account at this year’ virtual ASCO meeting with data showing that adjuvant (post-surgery) use of Tagrisso delays the recurrence of EGFR-positive non-smal

NICE clears front-line NHS use for Pfizer’s lung cancer drug...